HEART FAILURE NYHA CLASS II
Clinical trials for HEART FAILURE NYHA CLASS II explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE NYHA CLASS II trials appear
Sign up with your email to follow new studies for HEART FAILURE NYHA CLASS II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Nerve-Zapping device could cut heart failure deaths
Disease control ENROLLING_BY_INVITATIONThis study tests a device called Barostim that stimulates nerves to help control heart failure. It involves 2500 adults with moderate heart failure who still have symptoms despite standard medications. The goal is to see if the device reduces deaths and heart-related emergencies …
Matched conditions: HEART FAILURE NYHA CLASS II
Phase: NA • Sponsor: CVRx, Inc. • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Exercise with blood flow restriction or laser: which boosts a failing heart?
Symptom relief OngoingThis study tests whether blood flow restricted resistance exercises or low-level laser therapy can improve heart function in 60 adults aged 40-60 with stable chronic heart failure (NYHA class II). Participants will undergo one of the two treatments, and researchers will measure c…
Matched conditions: HEART FAILURE NYHA CLASS II
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated May 22, 2026 13:54 UTC
-
Heart failure study tracks metabolic shifts from common drug
Knowledge-focused ENROLLING_BY_INVITATIONThis study watches 40 adults with heart failure to see how SGLT2 inhibitors affect their body's energy use and blood markers. Participants do a walking test, a leg MRI, and give blood samples before and after starting the drug. The goal is to understand the early metabolic change…
Matched conditions: HEART FAILURE NYHA CLASS II
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:01 UTC